Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama, 226-8503, Japan.
School of Life Science and Technology, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama, 226-8503, Japan.
Chem Asian J. 2018 Dec 18;13(24):3818-3832. doi: 10.1002/asia.201801488. Epub 2018 Nov 5.
Peptide drugs have garnered much attention in recent years. However, conventional peptide synthesis requires an excess amount of expensive reagents of low atom economy, and the large amount of waste produced by these reagents complicates the purification of desired peptides. Solid-phase approaches simplify the purification of these peptides, but these require expensive solid-phase, excess amounts of reagents, substrates, and solvents. This makes it important to develop high-yielding, cost-effective, and less wasteful synthetic approaches. Micro-flow technology (reaction space ≤1 mm) has produced many advantages over conventional batch synthesis. The advantages include precise control of short reaction time and temperature, high levels of light penetration efficiency, lowered risks of handling dangerous compounds, and ready scale-up with high reproducibility. Micro-flow peptide syntheses using these advantages have been reported in recent years. This review summarizes the solid-phase and solution-phase syntheses of α- and β-peptides and of cyclic peptides using micro-flow technology.
近年来,肽类药物受到了广泛关注。然而,传统的肽合成需要过量的昂贵试剂,且这些试剂的原子经济性低,产生的大量废物使所需肽的纯化变得复杂。固相法简化了这些肽的纯化,但需要昂贵的固相、过量的试剂、底物和溶剂。因此,开发高产率、经济高效且浪费少的合成方法非常重要。微流技术(反应空间≤1 mm)与传统的分批合成相比具有许多优势。这些优势包括对短反应时间和温度的精确控制、高效的光穿透效率、降低处理危险化合物的风险,以及易于进行高重复性的放大。近年来,已有使用这些优势进行微流肽合成的报道。本文综述了使用微流技术进行固相和液相合成α-和β-肽以及环肽的方法。